scispace - formally typeset
A

Alfica Sehgal

Researcher at Alnylam Pharmaceuticals

Publications -  59
Citations -  3534

Alfica Sehgal is an academic researcher from Alnylam Pharmaceuticals. The author has contributed to research in topics: Gene & Small interfering RNA. The author has an hindex of 17, co-authored 57 publications receiving 2841 citations. Previous affiliations of Alfica Sehgal include Genzyme.

Papers
More filters
Journal ArticleDOI

Advanced siRNA Designs Further Improve In Vivo Performance of GalNAc-siRNA Conjugates

TL;DR: Liver exposure data indicate that the improvement in potency is predominantly due to increased metabolic stability of the siRNA conjugates, and this work employed an iterative screening approach across multiple siRNAs to arrive at advanced designs with low 2′-deoxy-2′-fluoro content that yield significantly improved potency and duration in preclinical species, including non-human primate.
Journal ArticleDOI

Impact of enhanced metabolic stability on pharmacokinetics and pharmacodynamics of GalNAc-siRNA conjugates.

TL;DR: Compared two siRNAs of the same sequence but with different modification pattern resulting in different degrees of protection against nuclease activity enhanced stability translated into substantially improved liver exposure, gene silencing efficacy and duration of effect in mice.